- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1459
1,459 companies
Bayer
Market Cap: €20.9b
Operates as a life science company worldwide.
BAYN
€21.27
7D
-6.2%
1Y
-25.5%
BioNTech
Market Cap: US$22.4b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
BNTX
US$92.01
7D
-3.6%
1Y
2.3%
Waters
Market Cap: US$21.5b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$345.12
7D
-6.9%
1Y
3.2%
Natera
Market Cap: US$19.4b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$138.71
7D
-6.5%
1Y
50.2%
Biogen
Market Cap: US$19.2b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$130.71
7D
-6.9%
1Y
-36.3%
Royalty Pharma
Market Cap: US$18.0b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$31.79
7D
0.4%
1Y
10.7%
Sandoz Group
Market Cap: CHF 15.3b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 35.54
7D
-4.8%
1Y
36.2%
Teva Pharmaceutical Industries
Market Cap: US$17.5b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$14.85
7D
-4.1%
1Y
6.6%
Astellas Pharma
Market Cap: JP¥2.5t
Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.
4503
JP¥1,392.00
7D
-5.8%
1Y
-13.1%
West Pharmaceutical Services
Market Cap: US$16.0b
Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
WST
US$219.97
7D
-2.7%
1Y
-43.0%
Summit Therapeutics
Market Cap: US$15.1b
A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom.
SMMT
US$18.91
7D
-8.2%
1Y
434.2%
Cipla
Market Cap: ₹1.2t
Engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally.
CIPLA
₹1,415.25
7D
-1.9%
1Y
-2.4%
United Therapeutics
Market Cap: US$14.0b
A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$307.36
7D
-0.2%
1Y
31.4%
Yunnan Baiyao GroupLtd
Market Cap: CN¥101.6b
Engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally.
000538
CN¥56.96
7D
1.4%
1Y
11.1%
ALTEOGEN
Market Cap: ₩19.5t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩363,000.00
7D
3.0%
1Y
125.5%
Insmed
Market Cap: US$13.3b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$73.33
7D
-5.6%
1Y
168.8%
Shionogi
Market Cap: JP¥1.9t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.
4507
JP¥2,325.50
7D
0.8%
1Y
-7.9%
ICON
Market Cap: US$13.2b
A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
ICLR
US$163.61
7D
-8.6%
1Y
-48.7%
WuXi Biologics (Cayman)
Market Cap: HK$101.8b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$24.85
7D
-10.5%
1Y
77.0%
BioMarin Pharmaceutical
Market Cap: US$13.0b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$67.48
7D
-7.3%
1Y
-22.3%
Illumina
Market Cap: US$13.0b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$76.42
7D
-7.1%
1Y
-39.3%
Revvity
Market Cap: US$12.8b
Provides health sciences solutions, technologies, and services worldwide.
RVTY
US$100.75
7D
-6.1%
1Y
-0.9%
Genmab
Market Cap: DKK 81.7b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,285.00
7D
-8.1%
1Y
-38.3%
Incyte
Market Cap: US$12.1b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$62.46
7D
2.9%
1Y
13.6%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.6b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€51.35
7D
-3.4%
1Y
3.1%
Dr. Reddy's Laboratories
Market Cap: ₹959.2b
Operates as an integrated pharmaceutical company worldwide.
500124
₹1,109.75
7D
-3.0%
1Y
-10.1%
Lupin
Market Cap: ₹956.2b
Operates as a pharmaceutical company in India and internationally.
500257
₹1,971.10
7D
-2.7%
1Y
23.3%
Avantor
Market Cap: US$11.1b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$15.67
7D
-3.1%
1Y
-37.6%
Neurocrine Biosciences
Market Cap: US$10.8b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$102.88
7D
-9.8%
1Y
-25.2%
Zydus Lifesciences
Market Cap: ₹907.5b
Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.
ZYDUSLIFE
₹866.90
7D
-2.2%
1Y
-13.9%
Innovent Biologics
Market Cap: HK$82.3b
A biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People’s Republic of China.
1801
HK$50.25
7D
9.6%
1Y
39.0%
Exelixis
Market Cap: US$10.4b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$36.68
7D
-0.4%
1Y
56.2%
Viatris
Market Cap: US$10.3b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$8.16
7D
-7.7%
1Y
-30.6%
Eurofins Scientific
Market Cap: €9.3b
Provides various analytical testing and laboratory services worldwide.
ERF
€49.33
7D
-0.4%
1Y
-19.7%
Moderna
Market Cap: US$9.9b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$25.73
7D
-17.3%
1Y
-75.0%
Akeso
Market Cap: HK$77.1b
A biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs.
9926
HK$85.90
7D
21.1%
1Y
88.4%